Sg Americas Securities, LLC Denali Therapeutics Inc. Transaction History

Sg Americas Securities, LLC

$30.5 Billion
Q1 2025

A detailed history of Sg Americas Securities, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 48,365 shares of DNLI stock, worth $773,356. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,365

Previous 11,003 339.56%

Holding current value

$773,356

Previous $224,000 193.75%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	BUY	$13.6 - $23.59 $508,123 - $881,369	37,362 Added 339.56%	48,365 $658,000
Q4 2024 Jan 17, 2025	BUY	$20.24 - $31.58 $125,386 - $195,638	6,195 Added 128.85%	11,003 $224,000
Q3 2024 Oct 03, 2024	SELL	$20.96 - $31.05 $188,640 - $279,450	-9,000 Reduced 65.18%	4,808 $140,000
Q2 2024 Jul 12, 2024	BUY	$14.96 - $23.22 $99,738 - $154,807	6,667 Added 93.36%	13,808 $321,000
Q1 2024 May 06, 2024	BUY	$15.83 - $23.35 $113,042 - $166,742	7,141 New	7,141 $147,000
Q3 2023 Oct 13, 2023	BUY	$20.63 - $30.17 $543,105 - $794,255	26,326 Added 277.88%	35,800 $739,000
Q2 2023 Jul 10, 2023	SELL	$23.37 - $32.96 $650,083 - $916,848	-27,817 Reduced 74.59%	9,474 $280,000
Q1 2023 Apr 28, 2023	BUY	$21.91 - $32.67 $717,442 - $1.07 Million	32,745 Added 720.3%	37,291 $859,000
Q4 2022 Feb 02, 2023	SELL	$26.28 - $33.92 $218,255 - $281,705	-8,305 Reduced 64.63%	4,546 $126,000
Q3 2022 Oct 31, 2022	SELL	$25.97 - $38.53 $687,296 - $1.02 Million	-26,465 Reduced 67.31%	12,851 $394,000
Q2 2022 Jul 29, 2022	BUY	$20.88 - $35.19 $633,415 - $1.07 Million	30,336 Added 337.82%	39,316 $1.16 Million
Q1 2022 Apr 29, 2022	SELL	$29.0 - $47.27 $690,838 - $1.13 Million	-23,822 Reduced 72.62%	8,980 $289,000
Q4 2021 Feb 07, 2022	BUY	$42.59 - $55.02 $81,219 - $104,923	1,907 Added 6.17%	32,802 $1.46 Million
Q3 2021 Nov 01, 2021	BUY	$48.48 - $78.23 $660,540 - $1.07 Million	13,625 Added 78.89%	30,895 $1.56 Million
Q2 2021 Aug 12, 2021	SELL	$50.3 - $78.44 $498,372 - $777,183	-9,908 Reduced 36.46%	17,270 $1.36 Million
Q1 2021 May 13, 2021	BUY	$53.8 - $81.53 $83,874 - $127,105	1,559 Added 6.09%	27,178 $1.55 Million
Q4 2020 Feb 04, 2021	SELL	$36.89 - $93.56 $2.12 Million - $5.38 Million	-57,528 Reduced 69.19%	25,619 $2.15 Million
Q3 2020 Nov 09, 2020	BUY	$23.13 - $38.84 $1.45 Million - $2.44 Million	62,766 Added 307.96%	83,147 $2.98 Million
Q2 2020 Jul 20, 2020	SELL	$16.01 - $28.82 $30,499 - $54,902	-1,905 Reduced 8.55%	20,381 $493,000
Q1 2020 Apr 30, 2020	BUY	$14.2 - $27.98 $100,621 - $198,266	7,086 Added 46.62%	22,286 $390,000
Q4 2019 Jan 28, 2020	SELL	$14.4 - $19.99 $286,704 - $398,000	-19,910 Reduced 56.71%	15,200 $265,000
Q3 2019 Nov 04, 2019	BUY	$15.32 - $21.92 $393,233 - $562,642	25,668 Added 271.85%	35,110 $538,000
Q2 2019 Jul 29, 2019	BUY	$18.5 - $28.14 $8,639 - $13,141	467 Added 5.2%	9,442 $196,000
Q1 2019 Apr 29, 2019	BUY	$17.99 - $24.65 $161,460 - $221,233	8,975 New	8,975 $208,000

Others Institutions Holding DNLI

# of Institutions

237

Shares Held

111M

Call Options Held

80K

Put Options Held

36.8K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.15B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Denali Therapeutics Inc. Transaction History